582 related articles for article (PubMed ID: 32631004)
21. Anatomical and functional responses in eyes with diabetic macular edema treated with "1 + PRN" ranibizumab: one-year outcomes in population of mainland China.
Lai K; Huang C; Li L; Gong Y; Xu F; Zhong X; Lu L; Jin C
BMC Ophthalmol; 2020 Jun; 20(1):229. PubMed ID: 32539744
[TBL] [Abstract][Full Text] [Related]
22. Correlation between Deep Capillary Plexus Perfusion and Long-Term Photoreceptor Recovery after Diabetic Macular Edema Treatment.
Moon BG; Um T; Lee J; Yoon YH
Ophthalmol Retina; 2018 Mar; 2(3):235-243. PubMed ID: 31047592
[TBL] [Abstract][Full Text] [Related]
23. Comparison of clinical outcomes of different components of diabetic macular edema on optical coherence tomography.
Hu Y; Wu Q; Liu B; Cao D; Dong X; Zhang L; Li T; Yang X; Yu H
Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2613-2621. PubMed ID: 31529324
[TBL] [Abstract][Full Text] [Related]
24. Optical Coherence Tomography Biomarkers in Predicting Treatment Outcomes of Diabetic Macular Edema after Ranibizumab Injections.
Chang YC; Huang YT; Hsu AY; Meng PP; Lin CJ; Lai CT; Hsia NY; Chen HS; Tien PT; Lin JM; Chen WL; Tsai YY
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984630
[No Abstract] [Full Text] [Related]
25. A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS).
Stefanickova J; Cunha-Vaz J; Ulbig M; Pearce I; Fernández-Vega Sanz A; Theodossiadis P; Kodjikian L; Izmailov A; Muston D; Vassilev Z; Lamotte B; Tückmantel C; Friedl S; Altemark A; Schwarz HJ; Katz T;
Acta Ophthalmol; 2018 Dec; 96(8):e942-e949. PubMed ID: 29696809
[TBL] [Abstract][Full Text] [Related]
26. Higher-Order Assessment of OCT in Diabetic Macular Edema from the VISTA Study: Ellipsoid Zone Dynamics and the Retinal Fluid Index.
Ehlers JP; Uchida A; Hu M; Figueiredo N; Kaiser PK; Heier JS; Brown DM; Boyer DS; Do DV; Gibson A; Saroj N; Srivastava SK
Ophthalmol Retina; 2019 Dec; 3(12):1056-1066. PubMed ID: 31473172
[TBL] [Abstract][Full Text] [Related]
27. Retinal Reflectivity Measurement for Cone Impairment Estimation and Visual Assessment After Diabetic Macular Edema Resolution (RECOVER-DME).
Guyon B; Elphege E; Flores M; Gauthier AS; Delbosc B; Saleh M
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6241-6247. PubMed ID: 29228252
[TBL] [Abstract][Full Text] [Related]
28. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Boiko EV; Maltsev DS
Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
Reddy RK; Pieramici DJ; Gune S; Ghanekar A; Lu N; Quezada-Ruiz C; Baumal CR
Ophthalmology; 2018 Oct; 125(10):1568-1574. PubMed ID: 29752001
[TBL] [Abstract][Full Text] [Related]
30. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO DETECT MACULAR CAPILLARY ISCHEMIA IN PATIENTS WITH INNER RETINAL CHANGES AFTER RESOLVED DIABETIC MACULAR EDEMA.
Moein HR; Novais EA; Rebhun CB; Cole ED; Louzada RN; Witkin AJ; Baumal CR; Duker JS; Waheed NK
Retina; 2018 Dec; 38(12):2277-2284. PubMed ID: 29068912
[TBL] [Abstract][Full Text] [Related]
31. Disorganization of Retinal Inner Layers and Ellipsoid Zone Disruption Predict Visual Outcomes in Central Retinal Vein Occlusion.
Chan EW; Eldeeb M; Sun V; Thomas D; Omar A; Kapusta MA; Galic IJ; Chen JC
Ophthalmol Retina; 2019 Jan; 3(1):83-92. PubMed ID: 30929820
[TBL] [Abstract][Full Text] [Related]
32. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
[TBL] [Abstract][Full Text] [Related]
33. Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms.
Mori K; Yoshida S; Kobayashi Y; Ishikawa K; Nakao S; Hisatomi T; Haruta M; Isihibashi T; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):735-741. PubMed ID: 31960130
[TBL] [Abstract][Full Text] [Related]
34. Optical Coherence Tomography Biomarkers in Bilateral Diabetic Macular Edema Patients with Asymmetric anti-VEGF Response.
Koc F; Güven YZ; Egrilmez D; Aydın E
Semin Ophthalmol; 2021 Aug; 36(5-6):444-451. PubMed ID: 33780313
[No Abstract] [Full Text] [Related]
35. Diabetic macular oedema treated with intravitreal anti-vascular endothelial growth factor - 2-4 years follow-up of visual acuity and retinal thickness in 566 patients following Danish national guidelines.
Hodzic-Hadzibegovic D; Sander BA; Monberg TJ; Larsen M; Lund-Andersen H
Acta Ophthalmol; 2018 May; 96(3):267-278. PubMed ID: 29240306
[TBL] [Abstract][Full Text] [Related]
36. OPTICAL COHERENCE TOMOGRAPHY BASELINE PREDICTORS FOR INITIAL BEST-CORRECTED VISUAL ACUITY RESPONSE TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN EYES WITH DIABETIC MACULAR EDEMA: The CHARTRES Study.
Santos AR; Costa MÂ; Schwartz C; Alves D; Figueira J; Silva R; Cunha-Vaz JG
Retina; 2018 Jun; 38(6):1110-1119. PubMed ID: 28613220
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Retinal Layer Thickness in Eyes with Resolved Diabetic Macular Edema Receiving Ranibizumab with Normal Eyes.
Rentiya ZS; Kherani S; Usmani B; Qazi MA; Sadiq MA; Iftikhar M; Nguyen QD; Shah SM; Sepah YJ;
Ophthalmologica; 2020; 243(1):27-36. PubMed ID: 31747663
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the effect of vitreomacular interface abnormalities on anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema by optical coherence tomography: A systematic review and meta-analysis.
Gong Y; Wang M; Li Q; Shao Y; Li X
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103555. PubMed ID: 37088331
[TBL] [Abstract][Full Text] [Related]
39. Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy.
Mikhail M; Stewart S; Seow F; Hogg R; Lois N
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1411-1418. PubMed ID: 29779188
[TBL] [Abstract][Full Text] [Related]
40. Prognostic role of optical coherence tomography after switch to dexamethasone in diabetic macular edema.
Cavalleri M; Cicinelli MV; Parravano M; Varano M; De Geronimo D; Sacconi R; Bandello F; Querques G
Acta Diabetol; 2020 Feb; 57(2):163-171. PubMed ID: 31375899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
